Market Overview:
The global erythromycin thiocyanate market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing demand for erythromycin thiocyanate in human and veterinary medication applications. North America is expected to dominate the global erythromycin thiocyanate market during the forecast period, owing to the presence of key players in this region and rising demand for erythromycin thiocyanate from pharmaceutical companies. Asia Pacific is projected to be the fastest growing region in terms of CAGR during the forecast period, owing to increasing investments by leading players in this region and rising demand for erythromycin thiocyanate from end-use industries such as pharmaceuticals and cosmetics.
Product Definition:
Erythromycin Thiocyanate is an antibiotic used to treat a number of infections, including bronchitis, pneumonia, and skin infections.
Purity
90% ≤ Purity ≤ 95%:
90% < Purity < 95% is also known as impure or crude erythromycin. It contains more than the specified amount of purine base which makes it unviable for use in pharmaceuticals. Crude erythromycin can be used in animal feed, but its usage is not recommended by the WHO and FDA due to high levels of Purine Nucleoside (PN) found in it.
Application Insights:
The global erythromycin thiocyanate market by application is divided into human medication and veterinary medication. The human segment dominated the overall market in terms of revenue in 2017, owing to the high usage of erythromycin for treating various infections in humans. Moreover, increasing incidences of multi-drug resistant bacteria are anticipated to drive the demand for antibiotics, which will further propel growth during the forecast period.
Vetmedication is expected to be one of the fastest growing segments over the forecast period due to rising awareness among practitioners and increased focus on disease prevention through vaccination among animals worldwide. Furthermore, a rise in animal feed supplements containing omega 3 fatty acids along with other essential nutrients has been observed globally as an attempt towards improving animal health conditions and preventing diseases caused due to nutritional deficiency among animals globally.
Regional Analysis:
North America was the largest regional market in 2017 and accounted for a share of more than 30%. The region is expected to maintain its dominance over the forecast period. This can be attributed to increasing erythromycin consumption coupled with rising awareness about drug safety & efficacy. In addition, presence of major manufacturers such as Pfizer Inc.; Elanco; and Zoetis will also help this region retain its position during the forecast years.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to rise in livestock farming activities across emerging economies including China, India, Indonesia, Philippines & Thailand. Moreover, growing demand for meat products along with supportive economic conditions are likely to boost market development further.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global erythromycin thiocyanate market is expected to benefit from the increasing prevalence of respiratory diseases such as asthma, bronchitis, and pneumonia. This is owing to the properties of erythromycin thiocyanate that help in the treatment of these diseases.
- Rising demand for generic drugs: The growth of the generics market is expected to drive demand for erythromycin thiocyanate in the coming years. This is because generic drugs are cheaper than branded drugs and are more accessible to patients across all income levels.
- Growing awareness about respiratory disorders: There has been a growing awareness among people about respiratory disorders in recent years, which is likely to boost demand for erythromycin thiocyanate in the coming years. This will be especially true in developing countries where access to quality healthcare services remains limited.
Scope Of The Report
Report Attributes
Report Details
Report Title
Erythromycin Thiocyanate Market Research Report
By Type
Purity <90%, 90% ≤ Purity ≤ 95%, Purity> 95%
By Application
Human Medication, Veterinary Medication
By Companies
Kelun Chuanning Biotechnology, Ercros S.A., HEC Group, Envee Drugs Pvt Ltd, Mehta Api, Abbvie, Ningxia Qiyuan, Calyx C & P, Alembic Pharma, SM Biomed, Anuh Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Erythromycin Thiocyanate Market Report Segments:
The global Erythromycin Thiocyanate market is segmented on the basis of:
Types
Purity <90%, 90% ≤ Purity ≤ 95%, Purity> 95%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Human Medication, Veterinary Medication
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Kelun Chuanning Biotechnology
- Ercros S.A.
- HEC Group
- Envee Drugs Pvt Ltd
- Mehta Api
- Abbvie
- Ningxia Qiyuan
- Calyx C & P
- Alembic Pharma
- SM Biomed
- Anuh Pharma
Highlights of The Erythromycin Thiocyanate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity <90%
- 90% ≤ Purity ≤ 95%
- Purity> 95%
- By Application:
- Human Medication
- Veterinary Medication
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Erythromycin Thiocyanate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Erythromycin thiocyanate is a medication used to treat bacterial infections. It works by killing the bacteria that is causing the infection.
Some of the key players operating in the erythromycin thiocyanate market are Kelun Chuanning Biotechnology, Ercros S.A., HEC Group, Envee Drugs Pvt Ltd, Mehta Api, Abbvie, Ningxia Qiyuan, Calyx C & P, Alembic Pharma, SM Biomed, Anuh Pharma.
The erythromycin thiocyanate market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Erythromycin Thiocyanate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Erythromycin Thiocyanate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Erythromycin Thiocyanate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Erythromycin Thiocyanate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Erythromycin Thiocyanate Market Size & Forecast, 2018-2028
4.5.1 Erythromycin Thiocyanate Market Size and Y-o-Y Growth
4.5.2 Erythromycin Thiocyanate Market Absolute $ Opportunity
Chapter 5 Global Erythromycin Thiocyanate Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Erythromycin Thiocyanate Market Size Forecast by Type
5.2.1 Purity <90%
5.2.2 90% ≤ Purity ≤ 95%
5.2.3 Purity> 95%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Erythromycin Thiocyanate Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Erythromycin Thiocyanate Market Size Forecast by Applications
6.2.1 Human Medication
6.2.2 Veterinary Medication
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Erythromycin Thiocyanate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Erythromycin Thiocyanate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Erythromycin Thiocyanate Analysis and Forecast
9.1 Introduction
9.2 North America Erythromycin Thiocyanate Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Erythromycin Thiocyanate Market Size Forecast by Type
9.6.1 Purity <90%
9.6.2 90% ≤ Purity ≤ 95%
9.6.3 Purity> 95%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Erythromycin Thiocyanate Market Size Forecast by Applications
9.10.1 Human Medication
9.10.2 Veterinary Medication
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Erythromycin Thiocyanate Analysis and Forecast
10.1 Introduction
10.2 Europe Erythromycin Thiocyanate Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Erythromycin Thiocyanate Market Size Forecast by Type
10.6.1 Purity <90%
10.6.2 90% ≤ Purity ≤ 95%
10.6.3 Purity> 95%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Erythromycin Thiocyanate Market Size Forecast by Applications
10.10.1 Human Medication
10.10.2 Veterinary Medication
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Erythromycin Thiocyanate Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Erythromycin Thiocyanate Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Erythromycin Thiocyanate Market Size Forecast by Type
11.6.1 Purity <90%
11.6.2 90% ≤ Purity ≤ 95%
11.6.3 Purity> 95%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Erythromycin Thiocyanate Market Size Forecast by Applications
11.10.1 Human Medication
11.10.2 Veterinary Medication
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Erythromycin Thiocyanate Analysis and Forecast
12.1 Introduction
12.2 Latin America Erythromycin Thiocyanate Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Erythromycin Thiocyanate Market Size Forecast by Type
12.6.1 Purity <90%
12.6.2 90% ≤ Purity ≤ 95%
12.6.3 Purity> 95%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Erythromycin Thiocyanate Market Size Forecast by Applications
12.10.1 Human Medication
12.10.2 Veterinary Medication
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Erythromycin Thiocyanate Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Erythromycin Thiocyanate Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Erythromycin Thiocyanate Market Size Forecast by Type
13.6.1 Purity <90%
13.6.2 90% ≤ Purity ≤ 95%
13.6.3 Purity> 95%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Erythromycin Thiocyanate Market Size Forecast by Applications
13.10.1 Human Medication
13.10.2 Veterinary Medication
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Erythromycin Thiocyanate Market: Competitive Dashboard
14.2 Global Erythromycin Thiocyanate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Kelun Chuanning Biotechnology
14.3.2 Ercros S.A.
14.3.3 HEC Group
14.3.4 Envee Drugs Pvt Ltd
14.3.5 Mehta Api
14.3.6 Abbvie
14.3.7 Ningxia Qiyuan
14.3.8 Calyx C & P
14.3.9 Alembic Pharma
14.3.10 SM Biomed
14.3.11 Anuh Pharma
